The Think Tank on Advancing Precision Medicine in Rare Cancers is a highly interactive one-day meeting that brings together clinicians, researchers, industry representatives, advocates, and patients to collaborate on common challenges in rare cancer research and treatment.
Leveraging the successful Think Tank model established through over a decade of TargetCancer Foundation meetings, it creates a collaborative environment where diverse perspectives and ideas thrive. This meeting also builds on the progress made through TargetCancer Foundation’s TCF-001 TRACK study, a nationwide, decentralized, patient-driven clinical trial studying precision medicine in rare cancers.
The 5th Annual Think Tank on Advancing Precision Medicine in Rare Cancers will take place at The State Room in Boston, MA on Thursday, November 12, 2026. Registration will open in August.
Agenda
The 2026 meeting agenda will be available soon! Click here to view past agendas and videos.
Early Career Investigator Abstracts
Call for Submissions!
We are pleased to invite early investigators (within 5 years of fellowship or terminal degree) from universities, medical, and scientific institutions to submit an abstract for the 2026 Think Tank on Advancing Precision Medicine in Rare Cancers.
The Evan Schumacher Fund for Rare Cancer Research Early Investigator Award
Encouraging Early Career Investigators to Make a Difference in Rare Cancers
The Evan Schumacher Fund for Rare Cancer Research Early Investigator Award honors the life of Evan Schumacher by supporting early career investigators who are focused on studying rare cancers. This year, the top three abstracts will receive a cash award along with the opportunity to present their research in front of rare cancer and precision medicine experts at the 2026 Think Tank on Advancing Precision Medicine in Rare Cancers.
- 1st: $4,000 award, plus an opportunity to present the abstract live at the Think Tank and also present the related poster at the evening reception.
- 2nd: $2,000 award, plus an opportunity to present the related poster at the evening reception.
- 3rd: $1,000 award, plus an opportunity to present the related poster at the evening reception.
The deadline to submit your abstract is Tuesday, September 8, 2026.
2026 Meeting Sponsors
2026 Steering Committee
A. John Iafrate, MD, PhD
Massachusetts General Hospital
Harvard Medical School
Razelle Kurzrock, MD, FACP
Froedtert and Medical College
of Wisconsin
What participants are saying
This was a fantastic #RareCancer #PrecisionMedicine meeting @targetcancer in Boston! So much enthusiasm from patients and patient advocates to move the field forward.
Vivek Subbiah, MD
Sarah Cannon Research Institute
Originally posted on Twitter
This is genuinely the best rare cancer meeting I have ever attended.
Razelle Kurzrock, MD, FACP
Froedtert and Medical College of Wisconsin
…thank you for allowing me to be a part of the discussion of challenges, goals, opportunities and best practices in addressing the needs of patients facing rare cancers. What a wonderful group of humans you gathered. I was so inspired.
Katie Ortman Doble
Patient Keynote Speaker,
2023 Think Tank on Advancing Precision Medicine in Rare Cancers
View and download materials from past meetings
2022
TCF-001 TRACK Molecular Tumor Board 2025:
Prostatic Urethral Cancer
Presented at the TargetCancer Foundation Think Tank on Advancing Precision Medicine in Rare Cancers, October 29, 2025, Boston MA
We are grateful to our industry partners for supporting these meetings and for their dedication to developing treatments for patients with rare cancers.
Join our Mailing List
TargetCancer Foundation
TargetCancer Foundation is a recognized 501(c)(3) charity, Tax ID 26-4510094.
All content and images copyright © 2026 TargetCancer Foundation. All rights reserved. | Privacy Policy
